This review is designed to systematically examine the available evidence about virtual reality exposure therapy’s (VRET) efficacy for phobias, critically describe some of the most important challenges in the field and discuss possible directions. Evidence reveals that virtual reality (VR) is an effective treatment for phobias and useful for studying specific issues, such as pharmacological compounds and behavioral manipulations, that can enhance treatment outcomes. In addition, some variables, such as sense of presence in virtual environments, have a significant influence on outcomes, but further research is needed to better understand their role in therapeutic outcomes. We conclude that VR is a useful tool to improve exposure therapy and it can be a good option to analyze the processes and mechanisms involved in exposure therapy and the ways this strategy can be enhanced. In the coming years, there will be a significant expansion of VR in routine practice in clinical contexts.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Papers of Particular Interest, Published Recently, Have Been Highlighted as: • Of importance •• Of major importance
McLuhan M. Understanding media. New York, editor. Signet; 1964.
Botella C, Perpiñá C, Baños RM, García-Palacios A. Virtual reality: a new clinical setting lab. Stud Health Technol Inform. 1998;58:73–81.
Riva G, Mantovani F, Capideville CS, Preziosa A, Morganti F, Villani D, et al. Affective interactions using virtual reality: the link between presence and emotions. CyberPsychology Behav. 2007;10:45–56.
Riva G, Botella C, Baños R, Mantovani F, García-Palacios A, Quero S, et al. Presence-inducing media for mental health applications. In: Immersed in media. Cham: Springer International Publishing; 2015. p. 283–332.
Newman MG, Szkodny LE, Llera SJ, Przeworski A. A review of technology-assisted self-help and minimal contact therapies for anxiety and depression: is human contact necessary for therapeutic efficacy? Clin Psychol Rev. 2011;31:89–103.
Botella C, Baños RR, García-Palacios A, Quero S. Virtual reality and other realities. In: Hofmann S, Asmundson G, editors. The science of cognitive behavioral therapy. New York: Academic; 2017.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
Opriş D, Pintea S, García-Palacios A, Botella C, Szamosközi Ş, David D. Virtual reality exposure therapy in anxiety disorders: a quantitative meta-analysis. Depress Anxiety. 2012;29:85–93.
Parsons TD, Rizzo AA. Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: a meta-analysis. J Behav Ther Exp Psychiatry. 2008;39:250–61.
Powers MB, Emmelkamp PMG. Virtual reality exposure therapy for anxiety disorders: a meta-analysis. J Anxiety Disord. 2008;22:561
•• Morina N, Ijntema H, Meyerbröker K, Emmelkamp PMG. Can virtual reality exposure therapy gains be generalized to real-life? A meta-analysis of studies applying behavioral assessments. Behav Res Ther. 2015;74:18–24. The meta-analysis shows the effect size of VRET interventions when laboratory tests are used to measure treatment outcomes. This is important in establishing the extent to which therapeutic gains can be translated into real-life situations
•• Ling Y, Nefs HT, Morina N, Heynderickx I, Brinkman WP. A meta-analysis on the relationship between self-reported presence and anxiety in virtual reality exposure therapy for anxiety disorders. PLoS One. 2014;6:9. This meta-analysis demonstrates the positive relationship between sense of presence and anxiety. Moreover, it shows that this relationship is moderated by different factors
Turner WA, Casey LM. Outcomes associated with virtual reality in psychological interventions: where are we now? Clin Psychol Rev. 2014;34:634–44.
Valmaggia LR, Latif L, Kempton MJ, Rus-Calafell M. Virtual reality in the psychological treatment for mental health problems: an systematic review of recent evidence. Psychiatry Res. 2016;236:189–95.
Chicchi Giglioli IA, Pallavicini F, Pedroli E, Serino S, Riva G. Augmented reality: a brand new challenge for the assessment and treatment of psychological disorders. Comput Math Methods Med. 2015:1–13.
Anderson PL, Price M, Edwards SM, Obasaju MA, Schmertz SK, Zimand E, et al. Virtual reality exposure therapy for social anxiety disorder: a randomized controlled trial. J Consult Clin Psychol. 2013;81:751–60.
Hofmann SG. Cognitive mediation of treatment change in social phobia. J Consult Clin Psychol. 2004;72:393–9.
• Botella C, Pérez-Ara MÁ, Bretón-López J, Quero S, García-Palacios A, Baños RM. In vivo versus augmented reality exposure in the treatment of small animal phobia: a randomized controlled trial. PLoS One. 2016;11:1–22. This is the first and only RCT on augmented reality. It shows that the efficacy of augmented reality is equal to that of in vivo exposure in treating small animal phobias
Ost LG. One-session treatment for specific phobias. Behav Res Ther. 1989;27:1–7.
Bouchard S, Dumoulin S, Robillard G, Guitard T, Klinger E, Forget H, et al. Virtual reality compared with in vivo exposure in the treatment of social anxiety disorder: a three-arm randomized controlled trial. Br J Psychiatry. 2017;210:276–283.
Czerniak E, Caspi A, Litvin M, Amiaz R, Bahat Y, Baransi H, et al. A novel treatment of fear of flying using a large virtual reality system. Aerosp Med Hum Perform. 2016;87:411–6.
• Kampmann IL, Emmelkamp PMG, Hartanto D, Brinkman W-P, Zijlstra BJH, Morina N. Exposure to virtual social interactions in the treatment of social anxiety disorder: a randomized controlled trial. Behav Res Ther. 2016;77:147–56. This study shows that VRET can be effective without additional cognitive components for social fears, comparing a VRET condition to an iVET condition in an individual approach, and including extensive virtual verbal interaction
Scholing A, Emmelkamp PMG. Exposure with and without cognitive therapy for generalized social phobia: effects of individual and group treatment. Behav Res Ther. 1993;31:667–81.
Hofmann SG, Otto MW. Cognitive-behavior therapy of social anxiety disorder: evidence-based and disorder specific treatment techniques. New York: Routledge; 2008.
Malbos E, Rapee RM, Kavakli M. A controlled study of agoraphobia and the independent effect of virtual reality exposure therapy. Aust N Z J Psychiatry. 2013;47:160–8.
Barlow DH. Clinical handbook of psychological disorders. New York: The Guilford Press; 2007.
Beck AT, Emery G. Anxiety disorders and phobias: a cognitive perspective. New York: Basic Books; 1985.
Craske MG. Anxiety disorders: psychological approaches to theory and treatment. Boulder: Westview Press; 1999.
Meyerbroeker K, Morina N, Kerkhof GA, Emmelkamp PMG. Virtual reality exposure therapy does not provide any additional value in agoraphobic patients: a randomized controlled trial. Psychother Psychosom. 2013;82:170–6.
Craske MG, Barlow DH. Mastery of anxiety and panic. 4th ed. Oxford: Oxford University Press; 2007.
Moldovan R, David D. One session treatment of cognitive and behavioral therapy and virtual reality for social and specific phobias. Preliminary results from a randomized clinical trial. J Evidence-Based Psychother. 2014;14:67–83.
Pelissolo A, Zaoui M, Aguayo G, Yao SN, Roche S, Ecochard R, et al. Virtual reality exposure therapy versus cognitive behavior therapy for panic disorder with agoraphobia: a randomized comparison study. J CyberTherapy Rehabil. 2012;5:35–43.
Cottraux J, Bouvard M, Légeron P. Méthodes et échelles d’évaluation des comportements. Editions d. Issy les Moulineaux: Editions d’Application Psychotechniques; 1985.
Landon TM, Barlow DH. Cognitive-behavioral treatment for panic disorder: current status. J Psychiatr Pract. 2004;10:211–26.
Castro WP, Roca Sánchez MJ, Pitti González CT, Bethencourt JM, de la Fuente Portero JA, Marco RG. Cognitive-behavioral treatment and antidepressants combined with virtual reality exposure for patients with chronic agoraphobia. Int J Clin Health Psychol. 2014;14:9–17.
Pitti CT, Peñate W, De La Fuente J, Bethencourt JM, Roca-Sánchez MJ, Acosta L, et al. The combined use of virtual reality exposure in the treatment of agoraphobia. Actas Esp Psiquiatr. 2015;4343:133–41133.
Triscari MT, Faraci P, Catalisano D, D’Angelo V, Urso V. Effectiveness of cognitive behavioral therapy integrated with systematic desensitization, cognitive behavioral therapy combined with eye movement desensitization and reprocessing therapy, and cognitive behavioral therapy combined with virtual reality expo. Neuropsychiatr Dis Treat. 2015;11:2591–8.
Heeter C. Being there: the subjective experience of presence. Presence Teleop Virt Environ. 1992;1:262–71.
Lee KM. Presence, explicated. Commun Theory. 2004;14:27–50.
Lombard M, Ditton T. At the heart of it all: the concept of presence. J Comput Commun. Blackwell Publishing Ltd; 2006;3.
McMahan A. Immersion, engagement, and presence: a method for analyzing 3-D video games. In: Wolf MJP, Bernard P, editors. Journal of anxiety disorders. New York: Routledge; 2003. p. 67–86.
Slater M, Wilbur S. A framework for immersive virtual environments (FIVE): speculations on the role of presence in virtual environments. Presence Teleop Virtual Environ. 1997;6:603–16.
Steuer J. Defining virtual reality: dimensions determining telepresence. Aust J Commun. 1992;42:73–93.
Witmer BG, Singer MJ. Measuring presence in virtual environments: a presence questionnaire. Presence Teleoper Virtual Environ. 1998;7:225–40.
Diemer J, Alpers GW, Peperkorn HM, Shiban Y, Mühlberger A. The impact of perception and presence on emotional reactions: a review of research in virtual reality. Front Psychol. 2015;6:1–9.
Botella C, Osma J, Garcia-Palacios A, Quero S, Baños RM. Treatment of flying phobia using virtual reality: data from a 1-year follow-up using a multiple baseline design. Clin Psychol Psychother. 2004;11:311–23.
Schubert T, Friedmann F, Regenbrecht H. The experience of presence: factor analytic insights. Presence Teleop Virtual Environ. 2001;10:266–81.
Sheridan TB. Descartes, Heidegger, Gibson, and god: toward an eclectic ontology of presence. Presence Teleop Virtual Environ. 1999;8:551–9.
Schuemie MJ, van der Straaten P, Krijn M, van der Mast CAPG. Research on presence in virtual reality: a survey. CyberPsychology Behav. 2001;4:183–201.
Regenbrecht HT, Schubert TW, Friedmann F. Measuring the sense of presence and its relations to fear of heights in virtual environments. Int J Hum Comput Interact. 1998;10:233–49.
Robillard G, Bouchard S, Fournier T, Renaud P. Anxiety and presence during VR immersion: a comparative study of the reactions of phobic and non-phobic participants in therapeutic virtual environments derived from computer games. CyberPsychology Behav. 2003;6:467–76.
Rothbaum BO, Hodges LF, Kooper R, Opdyke D, Williford JS, North M. Effectiveness of computer-generated (virtual reality) graded exposure in the treatment of acrophobia. Am J Psychiatry. 1995;152:626–8.
Wiederhold BK, Wiederhold MD. The effect of presence on virtual reality treatment. In: virtual reality therapy for anxiety disorders: advances in evaluation and treatment. Washington: American Psychological Association; 2005.
Krijn M, Emmelkamp PM, Biemond R, de Wilde de Ligny C, Schuemie MJ, van der Mast CAP. Treatment of acrophobia in virtual reality: the role of immersion and presence. Behav Res Ther. 2004;42:229–39.
Price M, Mehta N, Tone EB, Anderson PL. Does engagement with exposure yield better outcomes? Components of presence as a predictor of treatment response for virtual reality exposure therapy for social phobia. J Anxiety Disord. 2011;25:763–70.
Price M, Anderson P. The role of presence in virtual reality exposure therapy. J Anxiety Disord. 2007;21:742–51.
Schuemie MJ, Bruynzeel M, Drost L, Brinckman M, De Haan G, et al. Treatment of acrophobia in virtual reality: a pilot study. In: Broeckx, F, Pauwels L. (Eds.) Conference Proceedings Euromedia 2000 May 8–10; Antwerp, Belgium. Ostend, Belgium: EUROSIS – ETI Publications. p. 271–275.
Walshe D, Lewis E, O’Sullivan K, Kim SI. Virtually driving: are the driving environments “real enough” for exposure therapy with accident victims? An explorative study. Cyberpsychol Behav. 2005;8:532–7.
Kim K, Kim C-H, Cha KR, Park J, Han K, Kim YK, et al. Anxiety provocation and measurement using virtual reality in patients with obsessive-compulsive disorder. CyberPsychology Behav. 2008;11:637–41.
Ling Y, Brinkman W-P, Nefs HT, Qu C, Heynderickx I. Effects of stereoscopic viewing on presence, anxiety, and cybersickness in a virtual reality environment for public speaking. Presence Teleoper Virtual Environ. 2012;21:254–67.
Villani D, Repetto C, Cipresso P, Riva G. May I experience more presence in doing the same thing in virtual reality than in reality? An answer from a simulated job interview. Interact Comput Oxford University Press. 2012;24:265–72.
Peperkorn HM, Diemer J, Mühlberger A. Temporal dynamics in the relation between presence and fear in virtual reality. Comput Hum Behav. 2015;48:542–7.
Bouchard S, St-Jacques J, Robillard G, Renaud P. Anxiety increases the feeling of presence in virtual reality. Presence Teleoper Virtual Environ. 2008;17:376–91.
Baños R, Botella C, Liaño V, Guerrero B, Rey B, Alcañiz M. Sense of presence in emotional virtual environments. Presence. 2004:156–9.
Cummings JJ, Bailenson JN. How immersive is enough? A meta-analysis of the effect of immersive technology on user presence. 2015;1–38.
Fitzgerald PJ, Seemann JR, Maren S. Can fear extinction be enhanced? A review of pharmacological and behavioral findings. Brain Res Bull. 2014;105:46–60.
McGuire JF, Lewin AB, Storch EA. Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder. Expert Rev Neurother. 2014;14:893–910.
Hofmann SG, Otto MW, Pollack MH, Smits JA. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. Curr Psychiatry Rep. 2015;17:532.
• Mataix-Cols D, Fernández de la Cruz L, Monzani B, Rosenfield D, Andersson E, Pérez-Vigil A, et al. D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders. JAMA Psychiatry. 2017;22:1–10. This IPD meta-analysis synthesizes evidence for the role of DCS in enhancing exposure-based therapy for several disorders. DCS shows great improvement from pre-treatment to post-treatment, but not from pre-treatment to follow-up. Apart from the year of publication, no other moderator is found
Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, et al. Cognitive enhancers as adjuncts to psychotherapy. Arch Gen Psychiatry. 2004;61:1136.
Tart CD, Handelsman PR, DeBoer LB, Rosenfield D, Pollack MH, Hofmann SG, et al. Augmentation of exposure therapy with post-session administration of d-cycloserine. J Psychiatr Res. 2013;47:168–74.
Meyerbroeker K, Powers MB, Van Stegeren A, Emmelkamp PMG. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial. Psychother Psychosom. 2012;81:29–37.
de Quervain DJ-F, Bentz D, Michael T, Bolt OC, Wiederhold BK, Margraf J, et al. Glucocorticoids enhance extinction-based psychotherapy. Proc Natl Acad Sci. 2011;108:6621–5.
•• Shiban Y, Pauli P, Mühlberger A. Effect of multiple context exposure on renewal in spider phobia. Behav Res Ther. 2013;51:68–74. This study shows how changing the context during exposure can be important in reducing the return of fear at post treatment, even when the same results are not found at follow-up
Shiban Y, Peperkorn H, Alpers GW, Pauli P, Mühlberger A. Influence of perceptual cues and conceptual information on the activation and reduction of claustrophobic fear. J Behav Ther Exp Psychiatry. 2016;51:19–26.
Shiban Y, Brütting J, Pauli P, Mühlberger A. Fear reactivation prior to exposure therapy: does it facilitate the effects of VR exposure in a randomized clinical sample? J Behav Ther Exp Psychiatry. 2015;46:133–40.
Shiban Y, Fruth MB, Pauli P, Kinateder M, Reichenberger J, Mühlberger A. Treatment effect on biases in size estimation in spider phobia. Biol Psychol. 2016;121:146–52.
Meyerbröker K, Emmelkamp PMG. Virtual reality exposure therapy in anxiety disorders: a systematic review of process-and-outcome studies. Depress Anxiety. 2010;27:933–44.
Page S, Coxon M. Virtual reality exposure therapy for anxiety disorders: small samples and no controls? Front Psychol. 2016;7:1–4.
McCann RA, Armstrong CM, Skopp NA, Edwards-Stewart A, Smolenski DJ, June JD, et al. Virtual reality exposure therapy for the treatment of anxiety disorders: an evaluation of research quality. J Anxiety Disord. 2014;28(6):625–31.
Fleming TM, de Beurs D, Khazaal Y, Gaggioli A, Riva G, Botella C, et al. Maximizing the impact of e-therapy and serious gaming: time for a paradigm shift. Front psychiatry. 2016;7:65.
Wrzesien M, Bretón-López J, Botella C, Burkhardt J-M, Alcañiz M, Pérez-Ara MA, et al. How technology influences the therapeutic process: evaluation of the patient-therapist relationship in augmented reality exposure therapy and in vivo exposure therapy. Behav Cogn Psychother. 2013;41:505–9.
Wrzesien M, Botella C, Bretón-López J, Del Río Ganzález E, Burkhardt J-MM, Alcañiz M, et al. Treating small animal phobias using a projective-augmented reality system: a single-case study. Comput Hum Behav. 2015;49:343–53.
• Bailey JO, Bailenson JN. Considering virtual reality in children’s lives. J Child Media. 2017;11:107–13. This review describes the potential of a practically unexplored area in virtual reality, its application to children
Riva G, Baños RM, Botella C, Mantovani F, Gaggioli A. Transforming experience: the potential of augmented reality and virtual reality for enhancing personal and clinical change. Front Psychiatry. 2016;7:1–14.
Grenier S, Forget H, Bouchard S, Isere S, Belleville S, Potvin O, et al. Using virtual reality to improve the efficacy of cognitive-behavioral therapy (CBT) in the treatment of late-life anxiety: preliminary recommendations for future research. Int Psychogeriatr. 2015;27:1217–25.
Raghav K, Van Wijk AJ, Abdullah F, Islam MN, Bernatchez M, De Jongh A. Efficacy of virtual reality exposure therapy for treatment of dental phobia: a randomized control trial. BMC Oral Health. 2016;16:25.
Miloff A, Lindner P, Hamilton W, Reuterskiöld L, Andersson G, Carlbring P. Single-session gamified virtual reality exposure therapy for spider phobia vs. traditional exposure therapy: study protocol for a randomized controlled non-inferiority trial. Trials. 2016;17:60.
Rozental A, Magnusson K, Institutet K, Boettcher J, Andersson G, Carlbring P. For better or worse: an individual patient data meta-analysis of deterioration among participants receiving Internet-based cognitive behavior therapy. J Consuling Clin Psychol. 2017;85:160–77.
Lambert MJ. Handbook of psychotherapy and behavior change. Sixth ed. New Jersey: Wiley Blackwell; 2013.
• Lindner P, Miloff A, Hamilton W, Reuterskiöld L, Andersson G, Powers M, Carlbring P. Creating state of the art, next-generation Virtual reality exposure therapies for anxiety disorders using consumer hardware platforms: design considerations and future direction. Cogn Behav Ther; 2017. It reviews the current state of VR technology and analyzes the possibilities of using low-cost commercially available VR hardware. Challenges in the development, evaluation, and dissemination of VRET applications are discussed.
Kazdin AE, Blase SL. Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspect Psychol Sci. 2011;6:21–37.
Mitroff SR, Biggs AT, Adamo SH, Dowd EW, Winkle J, Clark K. What can 1 million trials tell us about visual search? Psychol Sci. 2015;41:1–5.
Cárdenas G, Botella C, Quero S, Baños R, Durán X, De Rosa A, et al. Efectividad del programa de tratamiento virtual flight con población mexicana effectiveness of the treatment program virtual flight with mexican population. Rev Argen Clin Psic. 2016;25:145–56.
Aymerich-Franch L, Kizilcec RF, Bailenson JN. The relationship between virtual self similarity and social anxiety. Front hum Neurosci. Frontiers. 2014;8:944.
Bailenson JN. Doppelgangers—a new form of self? Psychologist. 2012;25:36–8.
Miragall M, Baños RM, Cebolla A, Botella C. Working alliance inventory applied to virtual and augmented reality (WAI-VAR): psychometrics and therapeutic outcomes. Front Psychol. 2015;6:1–10.
This study was funded by the Ministry of Economy and Competitiveness (Spain), (Plan Nacional I + D + I. PSI2014-54172-R), and the Institute of Health Carlos III (ISCiii) CIBERobn is an initiative of ISCIII.
Conflict of Interest
Cristina Botella, Javier Fernández-Álvarez, Verónica Guillén, Azucena García-Palacios, and Rosa Baños declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
This article is part of the Topical Collection on Anxiety Disorders
About this article
Cite this article
Botella, C., Fernández-Álvarez, J., Guillén, V. et al. Recent Progress in Virtual Reality Exposure Therapy for Phobias: A Systematic Review. Curr Psychiatry Rep 19, 42 (2017). https://doi.org/10.1007/s11920-017-0788-4
- Virtual reality
- Mixed realities
- Psychological treatments
- Phobias interventions
- Systematic review